When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BYSI - BeyondSpring commences late-stage study of Plinabulin for preventing chemo-induced neutropenia
BeyondSpring Inc.
The first patient has been enrolled in a Phase 3 clinical trial, Study 106, evaluating BeyondSpring's (BYSI-4.1%) lead candidate Plinabulin for the prevention of chemotherapy-induced neutropenia (CIN) (abnormally low levels of a type of immune cell call neutrophils).
More news on: BeyondSpring Inc., Healthcare stocks news,